Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Recruiting · NCT05635162 · Registry updated 2025-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2025-04-16 | NCT05635162 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BeiGene | 47 |
| University College, London | 222 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 18 |
| Christie Hospital | Manchester | United Kingdom | 6 |
| Churchill Hospital | Oxford | United Kingdom | 17 |
| Clatterbridge Cancer Centre | Liverpool | United Kingdom | 5 |
| Derriford Hospital | Plymouth | United Kingdom | 27 |
| Guy's Hospital | London | United Kingdom | 14 |
| Norfolk and Norwich University Hospitl | Norwich | United Kingdom | 1 |
| Nottingham City Hospital | Nottingham | United Kingdom | 19 |
| Royal Cornwall Hospital | Truro | United Kingdom | 15 |
| Royal Derby Hospital | Derby | United Kingdom | 14 |
| Southampton General Hospital | Southampton | United Kingdom | 24 |
| St Bartholomew's Hospital | London | United Kingdom | 20 |
| University College London Hospital | London | United Kingdom | 32 |